ARS Pharmaceuticals (SPRY) Change in Inventory (2024 - 2026)

ARS Pharmaceuticals has disclosed Change in Inventory across 3 years of filings, most recently posting $294000.0 for Q1 2026.

• Change in Inventory for Q1 2026 came in at $294000.0, down 96.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.8 million (down 3.91% YoY), and the FY2025 annual result was $22.0 million, up 269.82% from the prior year.
• Change in Inventory came in at $294000.0 for Q1 2026 at ARS Pharmaceuticals, down from $9.7 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $9.7 million in Q4 2025 to a low of -$963000.0 in Q3 2025.
• The 3-year median for Change in Inventory is $4.8 million (2025), against an average of $4.0 million.
• Peak annual rise in Change in Inventory reached 68.64% in 2025, while the deepest fall reached 626.23% in 2025.
• ARS Pharmaceuticals' Change in Inventory stood at $5.8 million in 2024, then surged by 68.64% to $9.7 million in 2025, then slumped by 96.97% to $294000.0 in 2026.
• The last three Change in Inventory figures came in at $294000.0 (Q1 2026), $9.7 million (Q4 2025), and -$963000.0 (Q3 2025), per Business Quant data.